FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
1. Name and Address of Reporting Person * Gorsky Alex | 2. Issuer Name and Ticker or Trading Symbol JOHNSON & JOHNSON [ JNJ ] |
5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner __ X __ Officer (give title below) _____ Other (specify below) Chairman, CEO |
ONE JOHNSON & JOHNSON PLAZA | 3. Date of Earliest Transaction (MM/DD/YYYY) | |
NEW BRUNSWICK, NJ 08933 | 4. If Amendment, Date Original Filed (MM/DD/YYYY) |
6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 11/16/2018 | M | 144695.0000 | A | $62.2000 | 481254.0000 | D | |||
Common Stock | 11/16/2018 | M | 119770.0000 | A | $62.6200 | 601024.0000 | D | |||
Common Stock | 11/16/2018 | S | 264465.0000 | D | $145.9587(1) | 336559.0000 | D | |||
Common Stock | 495.0000(2) | I | By 401k | |||||||
Common Stock | 1074.0000(3) | I | By ESOP |
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Employee Stock Options (Right to Buy) | $62.2000 | 11/16/2018 | M | 144695.0000 | 1/11/2014 | 1/8/2021 | Common Stock | 144695.0000 | $0.0000 | 0.0000 | D | ||||
Employee Stock Options (Right to Buy) | $62.6200 | 11/16/2018 | M | 119770.0000 | 2/9/2013 | 2/7/2020 | Common Stock | 119770.0000 | $0.0000 | 0.0000 | D |
Explanation of Responses: | |
(1) | This transaction was executed in multiple trades at prices ranging from $145.73 to $146.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
(2) | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2018). |
(3) | Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (10/31/2018). |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Gorsky Alex ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK, NJ 08933 | X | Chairman, CEO |
Signatures | ||
Linda E. King, as attorney-in-fact for Alex Gorsky | 11/16/2018 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
Attachments
- Original document
- Permalink
Disclaimer
Johnson & Johnson published this content on 16 November 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 17 November 2018 00:53:06 UTC